Abstract
The biotechnology industry is one of the fastest growing industries in China and, with a market size of 1.2 billion consumers, the potential for its growth is enormous. With a vast network of state-supported academic and research institutions and a large number of scientists trained in topnotch universities worldwide, China also has a superior R&D infrastructure to support the discovery of biotechnology products. Nevertheless, for China’s biotechnology industry to be globally competitive, it needs to upgrade its product development processes for the purpose of enabling its products to obtain registration approvals worldwide and be more cost-effective. Specifically, issues such as qualityassurance, compliance to regulatory requirements, cost of goods and effective management must be addressed and resolved. In this regard, the Hong Kong Special Administrative Region (HKSAR) is poised to play a significant role in the development of biotechnology industry in China.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
